This tumor-derived DNA is subsequently recognized by the cGAS within APCs, such as DCs, located in the tumor microenvironment, thereby activating the STING pathway, leading to the production of substantial quantities of IFN-I in DCs. Here, CGAS is linked to neoplasm.